Advisor Partners II’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Advisor Partners II's LLY Position: Q3 2023 in Review
Advisor Partners II increased its Eli Lilly (LLY) stake by 1.6% in Q3 2023, buying an estimated $391K and bringing the position to 49,580 shares worth $26.6M. The position accounts for 1.07% of the portfolio, ranked #10.
Advisor Partners II first reported a position in LLY in Q3 2022 and has held it in 5 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Advisor Partners II held 49,580 shares of Eli Lilly worth $26.6M as of Q3 2023.
- Advisor Partners II bought 759 Eli Lilly shares in Q3 2023, an estimated $391K.
- Eli Lilly made up 1.07% of Advisor Partners II's portfolio in Q3 2023, its #10 holding.
- Advisor Partners II first reported a position in Eli Lilly in Q3 2022 and has held it in 5 quarters since.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.